UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic ...

Alzheimer's disease, which affects nearly 7 million Americans and is rapidly increasing among populations aged 55-70 globally, has seen diagnostic advancements thanks to plasma-based detection ...

Rochester, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced full ...

Lecanemab was evaluated in the phase 3, randomised, placebo-controlled, superiority double-blind Clarity AD trial, involving 1795 people aged 50-90 with early Alzheimer's disease.

Plasma Biomarker Panel for Early Alzheimer Disease Detection Plasma biomarkers show potential in detecting and monitoring Alzheimer's pathology in preclinical stages, aiding early interventions.

The company has established new global collaborations with laboratories and testing centers focused on Alzheimer’s disease detection, including ARUP Laboratories, Neurogen Biomarking, NSW Health ...

Machine learning methods enable computers to learn without being explicitly programmed and have multiple applications, for example, in the improvement of data mining algorithms.

Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease ...

Barre Class Form Tips There's a lot of new lingo to learn when you step in the studio. Here are the terms you need to know to keep your form on point and make the most of your hard work.

Artificial Intelligence Build a Smarter Brand for Just $25 Learn to build brand assets, write content, pitch ideas, and more using AI — all in a bundle under five hours.

These findings not only suggest a basis for disease pathogenesis but also support broader therapeutic opportunities for ART5803 across autoimmune neuropsychiatric disorders.